1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Compliance

Counterfeit Devices Entering US Through Europe, FDA Officials Say

 
• By Elizabeth Orr

“Transshipment,” in which illicit devices are shipped to European hubs before being passed along to the US, has reportedly been on the rise since the start of the COVID-19 pandemic.

Business People with Jigsaw Puzzle Forming World Map
• Source: Shutterstock

Counterfeit devices making their way into the US often stop in Europe along the way, a recent blog post from two US Food and Drug Administration officials claims.

“Criminal networks are increasingly sophisticated and capable of exploiting regulatory, legal, and other gaps to ship and/or transship illicit and potentially dangerous health products to the U.S., putting patients at...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Compliance

More from Policy & Regulation

FDA Rebukes Four Companies, Including One Overseas, For Procedural Failures

 
• By Brian Bossetta

The US FDA’s device center sent warning letters to three domestic device manufacturers and one German firm for failing to adhere to protocol on several issues.

EU Finalizes Framework For Joint Clinical Assessments Of High-Risk Devices

 
• By Amanda Maxwell

Second submission window for joint scientific consultations on a procedure to help prepare for joint clinical assessments will open from 2 to 30 June 2025.

Get Ready For International Harmonization Before Approaching QMSR Deadline, Says Regulatory Expert

 
• By Brian Bossetta

During MD&M East last week, regulatory consultant Darren Reeves reminded device manufacturers that the time to get ready to comply with the new Quality Management System Regulation is now.